packageTrabectedin

trabectedin

Extends from Pharmacolibrary.Interfaces.PartialSubstance (Identity and physicochemical constants of one drug (Drugs.Substances)).

Information

Trabectedin is an alkylating anticancer medicine used to treat sarcoma and ovarian cancer. It is authorised in the European Union and is used in cancer treatment, though one related marketing application was refused.

Summary written by glm-5.3-flash from Wikidata Q2637746 and the WHO ATC classification and the EMA medicines list; not checked by a person.

name:trabectedin
ATC codes:L01CX01
DrugBank:DB05109
PubChem CID:108150
ChEBI:84050
Wikidata:Q2637746
formula:C39H43N3O11S
molar mass:761.843 g/mol (PubChem CID 108150)
logP:3.4 (Drugs.Common 25.09, not verified)

Parameters

TypeNameDefaultDescription
Stringname (from PartialSubstance)""INN / common name
String[:]atcCodes (from PartialSubstance)fill("", 0)all WHO ATC codes of the drug
StringdrugbankId (from PartialSubstance)""e.g. DB00758
StringpubchemCid (from PartialSubstance)""PubChem compound id
StringchebiId (from PartialSubstance)""ChEBI id (number)
StringwikidataId (from PartialSubstance)""e.g. Q410238
Stringformula (from PartialSubstance)""molecular formula
Modelica.Units.SI.MolarMassM (from PartialSubstance)0molar mass; 0 = unknown
ReallogP (from PartialSubstance)Modelica.Constants.infoctanol-water partition coefficient (log10); inf = unknown